Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Ebastine Tablets

Approval Number

国药准字HJ20140855

CompanyAlmirall, LLC

Registration Date

November 30, 2023

Previous Approval Numbers

H20140855

Drug Information

Generic Name

依巴斯汀片

Trade Name

开思亭

Dosage Form

片剂

Strength

10mg

Drug Type

化学药品

Registration Date

November 30, 2023

Expiry Date

November 29, 2028

Company Information

Applicant Company

Company NameAlmirall, LLC

Company Address

Ronda General Mitre, 151 08022 BARCELONA SPAIN

Manufacturing Company

Company Name

industrias farmaceuticas almirall, s.a.

Company Address

Ctra. de Martorell 41-61 08740 Sant Andreu de la Barca-Barcelona Spain

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy